Navigation Links
Angelus says Home Office Banning Legal High Benzo Fury is "Papering over the Cracks"
Date:6/4/2013

LONDON, June 4, 2013 /PRNewswire/ --

The drugs charity Angelus, which raises awareness about the danger of legal highs, derided the Government ban on the drugs Benzo Fury and NBOMe as, "papering over the cracks".

These drugs (seven compounds in total) have been controlled for 12 months under a Temporary Class Drug Order. Angelus maintains that drug controls are not changing patterns of use and that the Government must invest in drug education and legislate to stop the sale of legal highs on the high street.

Last year, a new drug was discovered on average every six days (European Drug Monitoring Centre figures). The untested drugs can be bought very easily from hundreds of high street headshops and online. Hospitalisations from legal highs have increased by 358 percent.

The founder of Angelus, Maryon Stewart , said, "These are dangerous substances: Benzo Fury is a strong stimulant and NBOMe is a powerful psychedelic. So the Government is right to be concerned about them. But the answer cannot be just another series of bans, that doesn't change how young people think or act and to present it as such is just papering over the cracks.

" Drugs education is still optional in this country when young people need to learn about the massive risks they are taking with legal highs. We also want the Government to take firm action against these reckless retailers, like they have in Ireland and Portugal."

Chair of the Advisory Council on the Misuse of Drugs, Prof. Les Iversen said (15 May), "Our problem is to know how many of these are really being used in this country and how harmful they are. This is difficult because we can't possibly address all classes of compound at once, unless we and the government can think of clever ways of regulating."

Notes to editors:

1) Maryon Stewart lost her daughter to GBL and established the Angelus Foundation. It is the only drugs charity dedicated to combating legal highs and club drugs and launched a national campaign in October including the website http://www.whynotfindout.org. There is also a site for families http://www.angelusfoundation.com.

2) In July, Scotland's largest health board in Glasgow reported a 358% rise in the number of young people needing emergency treatment after taking legal highs. It many cases, patients only survived after "urgent specialist treatment".

3) A temporary class drug is a controlled drug within the meaning of the Misuse of Drugs Act 1971 and other relevant legislation. Importation, exportation, production and supply of a temporary class drug will be prohibited without lawful authority. Offences committed under the 1971 Act in relation to a temporary class drug will be subject to maximum penalties of 14 years' imprisonment and an unlimited fine on indictment, and 6 months' imprisonment and a £5,000 fine on summary conviction. Simple possession of a temporary class drug is not an offence. However, law enforcement officers will have powers to seize and destroy a temporary class drug.

4) There are a total of seven compounds to be controlled.

The stimulant substances recommended for control are:

5- and 6-APB: (1-(benzofuran-5-yl)-propan-2-amine and 1-(benzofuran-6-yl)-propan- 2-amine) and their N-methyl derivatives.

5- and 6-APDB: (1-(2,3-dihydro-1-benzofuran-5-yl)-propan-2-amine and 1-(2,3- dihydro-1-benzofuran-6-yl)-propan-2-amine), and their N-methyl derivatives

5- and 6-IT: (2-(1H-indol-5-yl)-1-methylethylamine and 2-(1H-indol-6-yl)-1- methylethylamine).

'NBOMe' compounds recommended for control are:

2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2- methoxyphenyl)methyl]ethanamine

2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine

2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine

2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine

http://www.angelusfoundation.com
Telephone: +44-(0)845-177-10-70
Angelus Foundation is a registered charity registered in England and Wales (Number 1139830).
Registered office: 50 Broadway, London, SW1H 0BL



'/>"/>
SOURCE Angelus Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Home Affairs Committees Drugs Report: Angelus Foundation Says the Prime Minister Should Not Have Rejected a Royal Commission
2. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
3. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
4. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
5. Nephros Appoints John C. Houghton as President and Chief Executive Officer
6. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
7. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
8. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
9. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
10. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
11. Marken Opens Branch Office In Seoul, South Korea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec 8, 2016 Research and ... Market Analysis and Trends - Adhesion Type, Application, Usability - Forecast ... ... Global Cardiology Electrodes Market is poised to grow at a CAGR ... trends that the market is witnessing include advancements in extracellular microelectrode ...
(Date:12/8/2016)... 8, 2016 Bodycad announced it has ... the accuracy, reproducibility and speed for 3D constructs ... small bone orthopaedic applications. These patents are critical ... orthopaedic restorations based on each patient,s distinct anatomy. ... company harnesses the world,s first suite of orthopaedic ...
(Date:12/8/2016)... , Dec. 8, 2016  A new study by ... the use of opioid therapy to treat chronic pain ... likelihood of more harmful consequences, including death. ... and Zankhana Mehta , M.D., authored the study ... chronic opioid therapy. The study was published in the ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... , ... "TransPanel Volume 2 is a package of fading panel transitions that ... of Pixel Film Studios. , TransPanel Volume 2 is a set of fading ... versatile transitions features presets with up to 4 panels with complementary line animations. ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... assistance from offices in Pasco and Richland, is initiating a charity drive to ... injuries resulting from a recent automobile collision. , On October 29th of ...
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, the game-changing dual ... opening of the Sober College Robert Pfeifer Memorial Learning Center at its location ... was attended by an overwhelming amount of alumni, family, colleagues and friends of ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... "I had ... an inventor from Winchester, Va. "I thought that if the nebulizer had a more ... rather than fearing them." , He developed the patent-pending NEBY to avoid the need ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
Breaking Medicine News(10 mins):